Procter & Gamble Company (The) $PG Stock Holdings Trimmed by Covea Finance

Covea Finance cut its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 39.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 39,649 shares of the company’s stock after selling 25,800 shares during the quarter. Covea Finance’s holdings in Procter & Gamble were worth $6,092,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in PG. Nova Wealth Management Inc. acquired a new position in shares of Procter & Gamble in the 1st quarter valued at about $26,000. Signature Resources Capital Management LLC lifted its holdings in Procter & Gamble by 67.9% in the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after acquiring an additional 72 shares during the last quarter. Quarry LP bought a new position in Procter & Gamble in the first quarter worth about $33,000. Mid American Wealth Advisory Group Inc. acquired a new position in Procter & Gamble in the second quarter valued at approximately $34,000. Finally, RMG Wealth Management LLC bought a new position in shares of Procter & Gamble during the second quarter valued at approximately $37,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of PG opened at $144.53 on Friday. The firm has a market capitalization of $337.72 billion, a PE ratio of 21.10, a P/E/G ratio of 4.87 and a beta of 0.39. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46. The firm has a 50-day moving average price of $146.94 and a 200 day moving average price of $152.97. Procter & Gamble Company has a 52-week low of $138.14 and a 52-week high of $179.99.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The company had revenue of $22.39 billion during the quarter, compared to analyst estimates of $22.23 billion. During the same period in the prior year, the business posted $1.93 EPS. The business’s revenue for the quarter was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 17th. Stockholders of record on Friday, October 24th were paid a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend was Friday, October 24th. Procter & Gamble’s payout ratio is currently 61.75%.

Analysts Set New Price Targets

A number of research firms recently issued reports on PG. Barclays reduced their price objective on Procter & Gamble from $153.00 to $151.00 and set an “equal weight” rating for the company in a research report on Monday, December 8th. BNP Paribas Exane cut their target price on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. JPMorgan Chase & Co. lowered their price target on shares of Procter & Gamble from $165.00 to $157.00 and set a “neutral” rating for the company in a research report on Thursday, December 18th. Jefferies Financial Group raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and increased their price objective for the stock from $156.00 to $179.00 in a report on Tuesday, December 16th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday. Thirteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $171.38.

Insiders Place Their Bets

In other Procter & Gamble news, COO Shailesh Jejurikar sold 3,986 shares of the company’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the completion of the sale, the chief operating officer directly owned 46,899 shares of the company’s stock, valued at approximately $7,139,434.77. This represents a 7.83% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Susan Street Whaley sold 2,408 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $366,569.84. Following the completion of the transaction, the insider directly owned 31,770 shares in the company, valued at $4,836,347.10. This represents a 7.05% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 30,308 shares of company stock valued at $4,611,852. 0.20% of the stock is currently owned by insiders.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.